Published in Diabetologia on June 01, 1999
Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. Biochem J (2003) 2.15
Advanced glycation: an important pathological event in diabetic and age related ocular disease. Br J Ophthalmol (2001) 1.37
Accelerated aging in glaucoma: immunohistochemical assessment of advanced glycation end products in the human retina and optic nerve head. Invest Ophthalmol Vis Sci (2007) 1.17
Dietary hyperglycemia, glycemic index and metabolic retinal diseases. Prog Retin Eye Res (2010) 1.06
Protection against methylglyoxal-derived AGEs by regulation of glyoxalase 1 prevents retinal neuroglial and vasodegenerative pathology. Diabetologia (2011) 1.04
Neurodegenerative diseases of the retina and potential for protection and recovery. Curr Neuropharmacol (2008) 0.97
Advanced glycation end products can induce glial reaction and neuronal degeneration in retinal explants. Br J Ophthalmol (2005) 0.95
NADPH Oxidase versus Mitochondria-Derived ROS in Glucose-Induced Apoptosis of Pericytes in Early Diabetic Retinopathy. J Ophthalmol (2010) 0.95
Inhibition of advanced glycation and absence of galectin-3 prevent blood-retinal barrier dysfunction during short-term diabetes. Exp Diabetes Res (2007) 0.94
Molecular mechanisms of diabetic retinopathy: potential therapeutic targets. Middle East Afr J Ophthalmol (2015) 0.88
Oat Attenuation of Hyperglycemia-Induced Retinal Oxidative Stress and NF-κB Activation in Streptozotocin-Induced Diabetic Rats. Evid Based Complement Alternat Med (2013) 0.85
Alterations in intervertebral disc composition, matrix homeostasis and biomechanical behavior in the UCD-T2DM rat model of type 2 diabetes. J Orthop Res (2015) 0.85
Pars plana vitrectomy for diabetic macular edema. Internal limiting membrane delamination vs posterior hyaloid removal. A prospective randomized trial. Graefes Arch Clin Exp Ophthalmol (2011) 0.84
Differential effects of glyoxalase 1 overexpression on diabetic atherosclerosis and renal dysfunction in streptozotocin-treated, apolipoprotein E-deficient mice. Physiol Rep (2014) 0.83
Aspalathin improves hyperglycemia and glucose intolerance in obese diabetic ob/ob mice. Eur J Nutr (2012) 0.81
KIOM-79 protects AGE-induced retinal pericyte apoptosis via inhibition of NF-kappaB activation in vitro and in vivo. PLoS One (2012) 0.80
Litsea japonica extract inhibits neuronal apoptosis and the accumulation of advanced glycation end products in the diabetic mouse retina. Mol Med Rep (2015) 0.78
Advanced glycation end products and diabetic retinopathy. J Ocul Biol Dis Infor (2013) 0.77
Diabetes-related adduct formation and retinopathy. J Ocul Biol Dis Infor (2011) 0.76
Antidiabetic effect of green rooibos (Aspalathus linearis) extract in cultured cells and type 2 diabetic model KK-A(y) mice. Cytotechnology (2014) 0.75
Effect of advanced glycation end products on the expression of hypoxia-inducible factor-1α and vascular endothelial growth factor proteins in RF/6A cells. Exp Ther Med (2013) 0.75
Chronic hyperglycemia induced via the heterozygous knockout of Pdx1 worsens neuropathological lesion in an Alzheimer mouse model. Sci Rep (2016) 0.75
Zerumbone, a Phytochemical of Subtropical Ginger, Protects against Hyperglycemia-Induced Retinal Damage in Experimental Diabetic Rats. Nutrients (2016) 0.75
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature (2000) 12.33
The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med (2001) 9.68
Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest (2001) 3.46
Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci U S A (2000) 3.36
Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science (1986) 3.36
Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann Intern Med (1984) 3.14
Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature (1998) 2.99
Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways. Proc Natl Acad Sci U S A (1997) 2.88
Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling. Science (1988) 2.87
Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem (2001) 2.30
The vertically based deep fascia turnover flap of the leg: anatomic studies and clinical applications. Plast Reconstr Surg (1997) 2.13
Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc Natl Acad Sci U S A (1991) 2.12
High-affinity-receptor-mediated uptake and degradation of glucose-modified proteins: a potential mechanism for the removal of senescent macromolecules. Proc Natl Acad Sci U S A (1985) 2.11
Prevalence of diabetes mellitus secondary to pancreatic diseases (type 3c). Diabetes Metab Res Rev (2012) 2.00
Glucose and diabetic vascular disease. FASEB J (1992) 2.00
Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization. Nat Med (1996) 1.99
Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis. J Clin Invest (1998) 1.90
Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem Biophys Res Commun (1990) 1.80
1997 Volvo Award winner in basic science studies. Immunohistologic markers for age-related changes of human lumbar intervertebral discs. Spine (Phila Pa 1976) (1997) 1.75
The cellular and molecular mechanisms of diabetic complications. Endocrinol Metab Clin North Am (1996) 1.73
High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells. J Clin Invest (1998) 1.71
The missing link: a single unifying mechanism for diabetic complications. Kidney Int Suppl (2000) 1.69
The biochemistry of the complications of diabetes mellitus. Annu Rev Biochem (1981) 1.66
Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? Diabetes (1999) 1.65
Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes. J Clin Invest (1994) 1.63
Significant progress in porcine islet mass isolation utilizing liberase HI for enzymatic low-temperature pancreas digestion. Transplantation (1999) 1.59
Hollow microspheres for use as a floating controlled drug delivery system in the stomach. J Pharm Sci (1992) 1.56
Scarpa's fascia flap: anatomic studies and clinical application. Plast Reconstr Surg (1997) 1.55
Focal macular ERGs in eyes after removal of macular ILM during macular hole surgery. Invest Ophthalmol Vis Sci (2001) 1.55
Insulin stimulates PKCzeta -mediated phosphorylation of insulin receptor substrate-1 (IRS-1). A self-attenuated mechanism to negatively regulate the function of IRS proteins. J Biol Chem (2001) 1.54
Osteopenia in HIV-infected women prior to highly active antiretroviral therapy. J Infect (2003) 1.52
Oral folate enhances endothelial function in hyperhomocysteinaemic subjects. Eur J Clin Invest (1999) 1.51
Covalent attachment of soluble proteins by nonenzymatically glycosylated collagen. Role in the in situ formation of immune complexes. J Exp Med (1983) 1.49
Faecal tumour M2 pyruvate kinase: a new, sensitive screening tool for colorectal cancer. Br J Cancer (2004) 1.48
Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine. Diabetes (1992) 1.47
Inhibition of cellular proliferation through IkappaB kinase-independent and peroxisome proliferator-activated receptor gamma-dependent repression of cyclin D1. Mol Cell Biol (2001) 1.46
Effect of long-term dietary protein intake on glucose metabolism in humans. Diabetologia (2000) 1.45
Prevention of early islet graft failure by selective inducible nitric oxide synthase inhibitors after pig to nude rat intraportal islet transplantation. Transplantation (2001) 1.42
Night time blood pressure in diabetic patients--the submerged portion of the iceberg? Nephrol Dial Transplant (1999) 1.39
Improvement of cardiac performance and metabolism in long-term diabetes mellitus after treatment with insulin [see comment]. Exp Clin Endocrinol Diabetes (1995) 1.39
High prevalence of vitamin D deficiency, secondary hyperparathyroidism and generalized bone pain in Turkish immigrants in Germany: identification of risk factors. Osteoporos Int (2006) 1.39
Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat. Diabetes (1998) 1.37
Nonenzymatic glycosylation of peripheral nerve protein in diabetes mellitus. Proc Natl Acad Sci U S A (1981) 1.36
Nerve growth factor prevents both neuroretinal programmed cell death and capillary pathology in experimental diabetes. Mol Med (1995) 1.36
Endothelial function is impaired in fit young adults of low birth weight. Cardiovasc Res (1998) 1.34
Novel macrophage receptor for glucose-modified proteins is distinct from previously described scavenger receptors. J Exp Med (1986) 1.32
Hyperglycaemia-induced superoxide production decreases eNOS expression via AP-1 activation in aortic endothelial cells. Diabetologia (2004) 1.32
Accumulation of diabetic rat peripheral nerve myelin by macrophages increases with the presence of advanced glycosylation endproducts. J Exp Med (1984) 1.32
Indoxyl sulfate increases the gene expressions of TGF-beta 1, TIMP-1 and pro-alpha 1(I) collagen in uremic rat kidneys. Kidney Int Suppl (1997) 1.30
Activation of protein kinase C zeta induces serine phosphorylation of VAMP2 in the GLUT4 compartment and increases glucose transport in skeletal muscle. Mol Cell Biol (2001) 1.30
BCL-2 expression or antioxidants prevent hyperglycemia-induced formation of intracellular advanced glycation endproducts in bovine endothelial cells. J Clin Invest (1996) 1.28
Hyperglycaemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries is mediated by intracellular methylglyoxal levels in a pathway dependent on oxidative stress. Diabetologia (2010) 1.27
Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction. Diabetes (1999) 1.25
Characterization of polymorphs of tranilast anhydrate and tranilast monohydrate when crystallized by two solvent change spherical crystallization techniques. J Pharm Sci (1991) 1.25
Pancreatic exocrine function in patients with type 1 and type 2 diabetes mellitus. Acta Diabetol (2000) 1.24
Hyperhomocysteinemia after an oral methionine load acutely impairs endothelial function in healthy adults. Circulation (1998) 1.22
Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA. Eur J Clin Chem Clin Biochem (1997) 1.21
Advanced glycosylation endproducts on erythrocyte cell surface induce receptor-mediated phagocytosis by macrophages. A model for turnover of aging cells. J Exp Med (1987) 1.21
NF-AT-Driven interleukin-4 transcription potentiated by NIP45. Science (1996) 1.21
Neurochemical characterization of hypothalamic cocaine- amphetamine-regulated transcript neurons. J Neurosci (1999) 1.20
Comparative analysis of organ-specific autoantibodies and celiac disease--associated antibodies in type 1 diabetic patients, their first-degree relatives, and healthy control subjects. Diabetes Care (2001) 1.19
A vascular basis for repetitive strain injury. Rheumatology (Oxford) (1999) 1.17
The dynamics of gene expression of interleukin-19 and interleukin-20 and their receptors in psoriasis. Br J Dermatol (2005) 1.17
N(epsilon)(carboxymethyl)lysin and the AGE receptor RAGE colocalize in age-related macular degeneration. Invest Ophthalmol Vis Sci (1999) 1.16
Nonenzymatic glycosylation products on collagen covalently trap low-density lipoprotein. Diabetes (1985) 1.16
Role of advanced glycosylation products in complications of diabetes. Diabetes Care (1989) 1.16
Molecular cloning of a novel thyroid hormone-responsive gene, ZAKI-4, in human skin fibroblasts. J Biol Chem (1996) 1.16
AP-1 proteins mediate hyperglycemia-induced activation of the human TGF-beta1 promoter in mesangial cells. J Am Soc Nephrol (2000) 1.15
Nerve growth factor administration protects against experimental diabetic sensory neuropathy. Brain Res (1994) 1.14
Islet transplantation inhibits diabetic retinopathy in the sucrose-fed diabetic Cohen rat. Invest Ophthalmol Vis Sci (1993) 1.13
A glucose-controlled insulin-delivery system: semisynthetic insulin bound to lectin. Science (1979) 1.12
Hyperglycemia potentiates collagen-induced platelet activation through mitochondrial superoxide overproduction. Diabetes (2001) 1.12
Indoxyl sulfate stimulates renal synthesis of transforming growth factor-beta 1 and progression of renal failure. Kidney Int Suppl (1997) 1.12
Prolonged survival of pancreatic islet allografts mediated by adenovirus immunoregulatory transgenes. Proc Natl Acad Sci U S A (1995) 1.11
Aminoguanidine inhibits reactive oxygen species formation, lipid peroxidation, and oxidant-induced apoptosis. Diabetes (1998) 1.10
Measurement of glycosylated amino acids and peptides from urine of diabetic patients using affinity chromatography. Diabetes (1980) 1.10
Ethyl glucuronide--a marker of alcohol consumption and a relapse marker with clinical and forensic implications. Alcohol Alcohol (1999) 1.09
Increased serum levels of the specific AGE-compound methylglyoxal-derived hydroimidazolone in patients with type 2 diabetes. Metabolism (2003) 1.09
AMPA receptors in the therapeutic management of depression. CNS Neurol Disord Drug Targets (2007) 1.08
Ischaemia is linked to inflammation and induction of angiogenesis in pancreatic islets. Clin Exp Immunol (2006) 1.07
Enteral absorption of insulin in rats from mucoadhesive chitosan-coated liposomes. Pharm Res (1996) 1.07
Glomerular basement membrane metabolism in the diabetic rat. In vivo studies. Diabetes (1979) 1.07
Dose escalation and pharmacokinetic study of a humanized anti-HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. Br J Cancer (1999) 1.05
epsilon-Amino-lysine-bound glucose in human tissues obtained at autopsy. Increase in diabetes mellitus. Diabetes (1982) 1.05
Angiogenic capacity of endothelial cells in islets of Langerhans. FASEB J (2003) 1.05
Discovery, isolation and structure of novel cephamycins of Streptomyces chartreusis. J Antibiot (Tokyo) (1983) 1.05
Assessment of intracellular insulin content during all steps of human islet isolation procedure. Cell Transplant (1999) 1.05
Molecular mechanism of diabetic nephropathy. Clin Chim Acta (2000) 1.04
Recognition and uptake of human diabetic peripheral nerve myelin by macrophages. Diabetes (1985) 1.04
Studies on antibiotic SF-733, a new antibiotic. I. Taxonomy, isolation and characterization. J Antibiot (Tokyo) (1970) 1.04
Angiotensin II induces human TGF-beta 1 promoter activation: similarity to hyperglycaemia. Diabetologia (2002) 1.04
Protection against methylglyoxal-derived AGEs by regulation of glyoxalase 1 prevents retinal neuroglial and vasodegenerative pathology. Diabetologia (2011) 1.04
An oral sorbent reduces overload of indoxyl sulphate and gene expression of TGF-beta1 in uraemic rat kidneys. Nephrol Dial Transplant (2000) 1.03
Excessive nonenzymatic glycosylation of peripheral and central nervous system myelin components in diabetic rats. Diabetes (1983) 1.02
Modification of vitronectin by advanced glycation alters functional properties in vitro and in the diabetic retina. Lab Invest (1996) 1.02